Spots Global Cancer Trial Database for Neoadjuvant or Adjuvant Chemotherapy in Patients With Operable Non-small-cell Lung Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Neoadjuvant or Adjuvant Chemotherapy in Patients With Operable Non-small-cell Lung Cancer
Official Title: Randomized Trial of Surgery With or Without Paclitaxel Plus Carboplatin as Neoadjuvant or Adjuvant Chemotherapy in Patients With Operable, Non-small-cell Lung Cancer
Study ID: NCT00913705
Conditions
Study Description
Brief Summary: Open-label multicenter randomized Phase III trial.
Detailed Description: Randomized trial of surgery with or without Paclitaxel (taxol) plus Carboplatin as neoadjuvant or adjuvant chemotherapy in patients with operable, non-small-cell lung cancer.
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Contact Details
Name: Enriqueta Felip, MD
Affiliation: HOSPITAL VALL D'HEBRON (Barcelona)
Role: PRINCIPAL_INVESTIGATOR
Name: Rafael Rosell, MD
Affiliation: ICO-HOSPITAL UNIV. GERMANS TRIAS I PUJOL (Badalona)
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
